<!DOCTYPE html>
<html lang="en">
    <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
        <title>17</title>

        <link href="bootstrap.min.css" rel="stylesheet">
        <link href="custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="treatments.css" rel="stylesheet" type="text/css"/>
        <link href="recreated_tables.css" rel="stylesheet" type="text/css"/>
           <style>
        .sep {
            border-bottom:1px solid lightgray;
        }
        .sep td {
            padding-bottom:5px;
            padding-top:5px;
        }
        br {
            display: block;
            margin-top: 5px 0;
        }
    </style>
    </head>
    <body>
            <br />
            <div class="container">
                <ol class="breadcrumb small">
                
                        <li class="active">Gonorrhea</li><li class="active">Adolescents & Adults</li><li class="active">Pharynx - Infection</li>
                </ol>
              </div><!-- end of breadcrumbs -->
            
        <div class="container">
        <div id="table">
            <div id="regimen_header">Recommended Regimens 
            </div>
            <hr/>
            <span class="regimen_text">Ceftriaxone 250 mg IM in a single dose
            <div id="or">PLUS</div>Azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice a day for 7 days*
            </span>

            <hr/>
                <p class="regimen_footer_text">* Because of the high prevalence of tetracycline resistance among Gonococcal Isolate Surveillance Project isolates, particularly those with elevated minimum inhibitory concentrations to cefixime, the use of azithromycin as the second antimicrobial is preferred. </p>
        </div>
        <br />

        </div>
            </div>
        </div>
    </body>
</html>
        